View Older Stories View More Recent Stories
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Eastman CFO Willie McLain to address the Citi Basic Materials Conference
-
Form 10-D Citigroup Commercial For: Nov 13
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Air Products Leadership to Speak at Citi's Basic Materials Conference
-
Quantifind Recognized in Chartis RiskTech100 2026 for AI Precision, Speed, and Scalability--Ranking Above Well-Known Financial Crime and Compliance Vendors
-
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in December
-
Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting
-
Citi Opens 30-Day Positive Catalyst Watch on Agios Pharma (AGIO)
-
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Fortrea to Present at Upcoming Citi and Evercore Healthcare Conferences
-
Citi Starts Agios Pharma (AGIO) at Buy, PT $38
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Form 424B2 CITIGROUP INC
-
Citi Upgrades Oxford Industries (OXM) to Neutral
-
4th AMRO Forum: Deepen ASEAN+3 Integration for Resilience Amid Fragmentation
-
Citi Starts Rhythm Pharmaceuticals (RYTM) at Buy, PT $136
-
Analog Devices set to report above-consensus results amid seasonal industry slowdown
-
Dick’s Sporting Goods Q3 earnings preview: strong sales, steady profit expected

